Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction. Heart failure (HF) is a serious condition characterized by the heart’s inability […]

thaipr.net

20 ม.ค. 64

PureCircle and Almendra Resolve U.S. Patent Litigation

Amicable settlement reached PureCircle and Almendra reached an amicable settlement in a patent dispute in the United States relating to Almendra’s Steviarome® products and use thereof. As of December 31, 2020, PureCircle and Almendra voluntarily resolved the litigation with all claims and counterclaims subsequently being dismissed. As part of the settlement, Almendra signed a license agreement […]

thaipr.net

20 ม.ค. 64
1 3,292 3,293 3,294 3,295 3,296 3,411